Search for: "GLAXOSMITHKLINE LLC"
Results 81 - 100
of 182
Sort by Relevance
|
Sort by Date
28 Sep 2016, 8:39 am
(cross-petition asks for recourse on failure to dance) Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
18 Sep 2016, 6:03 pm
(cross-petition asks for recourse on failure to dance) Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
5 Sep 2016, 6:46 pm
(cross-petition asks for recourse on failure to dance) Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
5 Apr 2016, 2:12 am
by Dennis Crouch As part of a litigation settlement agreement, GlaxoSmithKline LLC (“GSK”) granted an exclusive generic marketing license to the challenger Teva for sales of lamotrigine and also agreed not to introduce its own competitive ‘authorized generic’ version. [read post]
8 Mar 2016, 11:22 am
Lafleur, a minor, filed suit against GlaxoSmithKline LLC on February 23 in the U.S. [read post]
23 Nov 2015, 12:13 pm
Numerous plaintiffs from across the country have initiated lawsuits against drug manufacturer GlaxoSmithKline, LLC, alleging that its drug Zofran caused a host of birth defects like cleft palate, club foot, and heart defects. [read post]
17 Jul 2015, 12:50 pm
From their legal document "BRIEF IN SUPPORT OF DEFENDANT GLAXOSMITHKLINE LLC’S MOTION FOR TRANSFER OF ACTIONS PURSUANT TO 28 U.S.C. [read post]
15 Feb 2015, 12:58 pm
GlaxoSmithKline LLC, 713 F.3d 1090, 1095 (Fed. [read post]
2 Jan 2015, 10:15 am
MacKay did seek a valuation of his own.But MacKay began to regret the share sale by February 2009, when he learned that Stiefel got two competing bids: one in November 2008 from Sanofi-Aventis ($2.8 billion), and another in March 2009 from GlaxoSmithKline (GSK) ($2.9 billion in cash after an initial bid of $3.1 billion). [read post]
25 Nov 2014, 9:55 pm
• Defendants: Glaxosmithkline LLC; Aptalis Pharma US, Inc.; Aptalis Pharmatech, Inc.; Aptalis Pharma Canada Inc. [read post]
16 Oct 2014, 6:17 am
Here are the materials in GlaxoSmithKline LLC v. [read post]
13 Oct 2014, 4:39 pm
The United States Court of Appeals for the Third Circuit has ordered that a drug defect lawsuit against GlaxoSmithKline LLC over its Paxil antidepressant medication be sent back to a state court. [read post]
23 Sep 2014, 12:01 pm
GlaxoSmithKline, LLC, Dist. [read post]
27 Jul 2014, 9:38 pm
GlaxoSmithKline LLC et al. v. [read post]
23 Jun 2014, 7:45 am
In re GlaxoSmithKline, LLC, No. 14-2051 (7th Cir. [read post]
1 May 2014, 9:58 pm
Noonan -- Last week, Sherry Knowles, former chief patent counsel for GlaxoSmithKline and now principal at Knowles Intellectual Property Strategies, LLC submitted to Managing Intellectual Property magazine a detailed critique of the U.S. [read post]
11 Mar 2014, 10:00 pm
In GlaxoSmithKline LLC v. [read post]
10 Mar 2014, 11:31 am
Here’s another “little list” that came about because of Bexis updating chapter two (information-based claims) of his book. [read post]
7 Mar 2014, 9:00 am
FMR LLC, which was handed down on Tuesday. [read post]
26 Feb 2014, 9:59 pm
Noonan -- The Federal Circuit issued an opinion on Monday in GlaxoSmithKline LLC v. [read post]